- Home
- TNGX vs USGOW Comparison
TNGX vs USGOW Comparison
Compare TNGX & USGOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- USGOW
- Stock Information
- Founded
- TNGX 2014
- USGOW 2015
- Country
- TNGX United States
- USGOW Canada
- Employees
- TNGX N/A
- USGOW 9
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- USGOW Precious Metals
- Sector
- TNGX Health Care
- USGOW Basic Materials
- Exchange
- TNGX Nasdaq
- USGOW Nasdaq
- Market Cap
- TNGX 723.2M
- USGOW N/A
- IPO Year
- TNGX N/A
- USGOW N/A
- Fundamental
- Price
- TNGX $6.82
- USGOW $0.83
- Analyst Decision
- TNGX Strong Buy
- USGOW
- Analyst Count
- TNGX 6
- USGOW 0
- Target Price
- TNGX $10.00
- USGOW N/A
- AVG Volume (30 Days)
- TNGX 1.5M
- USGOW 16.4K
- Earning Date
- TNGX 11-05-2025
- USGOW 02-14-2025
- Dividend Yield
- TNGX N/A
- USGOW N/A
- EPS Growth
- TNGX N/A
- USGOW N/A
- EPS
- TNGX N/A
- USGOW N/A
- Revenue
- TNGX $24,296,000.00
- USGOW N/A
- Revenue This Year
- TNGX $6.56
- USGOW N/A
- Revenue Next Year
- TNGX N/A
- USGOW N/A
- P/E Ratio
- TNGX N/A
- USGOW N/A
- Revenue Growth
- TNGX N/A
- USGOW N/A
- 52 Week Low
- TNGX $1.03
- USGOW $0.27
- 52 Week High
- TNGX $10.81
- USGOW $2.80
- Technical
- Relative Strength Index (RSI)
- TNGX 52.79
- USGOW N/A
- Support Level
- TNGX $6.25
- USGOW N/A
- Resistance Level
- TNGX $6.90
- USGOW N/A
- Average True Range (ATR)
- TNGX 0.41
- USGOW 0.00
- MACD
- TNGX -0.04
- USGOW 0.00
- Stochastic Oscillator
- TNGX 49.57
- USGOW 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About USGOW U.S. GoldMining Inc. Warrant
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.